Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Population Health Research Institute · Hamilton Health Sciences · +46 more institutions
Indexed incrossrefdatacite
Abstract
No abstract available for this paper.
Citation impact
875
total citations
- FWCI
- 71.59
- Percentile
- 100%
- References
- 30
Citations per year
Authors
644- SSSonia S. AnandCorresponding
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- JBJackie Bosch
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- JWJohn W. Eikelboom
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- SJStuart J. Connolly
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- RDRafael Díaz
Instituto Cardiovascular de Rosario
Topics & keywords
Topics
Keywords
- Rivaroxaban
- Medicine
- Aspirin
- Placebo
- Arterial disease
- Double blind
- Internal medicine
- Carotid artery disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.